Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.965 USD | +1.33% | -0.60% | -12.21% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.21% | 337M | |
+52.40% | 55.7B | |
+40.66% | 39.91B | |
-6.09% | 39.57B | |
-5.56% | 28.16B | |
+15.91% | 26.3B | |
-20.30% | 18.94B | |
+31.76% | 12.17B | |
+26.55% | 12.12B | |
+0.96% | 12.12B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- Transcript : C4 Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 10